НОВЫЙ ПОДХОД К ЛЕЧЕНИЮ ОНКОЗАБОЛЕВАНИЙ

Dorofeĭchuk Vg, Потехин Павел Павлович, Шер Стелла Абельевна · Педиатрическая фармакология · 2010

Oncological diseases are the second leading cause of deaths. Immune system disorders and enzymatic imbalances undoubtedly play a role in the development of tumors. Despite the multifactorial nature of oncological pathology development, endogenous lysozyme deficiency is an important condition of a disease nosogenesis. The article provides a theoretical and experimental validation for the use of lysozyme and antioxidant agents as an alternative therapy for oncological diseases. Key words: oncological diseases, lycozyme, isoantigens, muramine, free radicals. (Pediatric Pharmacology. – 2010; 7(4):37-39)

Cited by 0 works.

Authors